We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+13.33%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$54.8B
AUM Growth
+$4.24B
(+8.4%)
Cap. Flow
-$502M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
29.94%
Holding
1,776
New
37
Increased
449
Reduced
1,142
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$158M |
| 2 |
Uber
UBER
|
+$110M |
| 3 |
Blackstone Secured Lending
BXSL
|
+$97.3M |
| 4 |
Amazon
AMZN
|
+$76.3M |
| 5 |
PayPal
PYPL
|
+$75.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$184M |
| 2 |
Crown Castle
CCI
|
+$173M |
| 3 |
CME Group
CME
|
+$125M |
| 4 |
Gilead Sciences
GILD
|
+$119M |
| 5 |
Amgen
AMGN
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.81% |
| 2 | Healthcare | 15.16% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Moelis & Co
MC
$4.97B
| $1.3M | ﹤0.01% |
22,895
-1,155
| -5% | -$63.1K |
|
1152
Steven Madden
SHOO
$3.18B
| $1.3M | ﹤0.01% |
30,696
-1,548
| -5% | -$65.3K |
|
1153
Organon & Co
OGN
$3.56B
| $1.3M | ﹤0.01% |
69,009
-3,481
| -5% | -$59.7K |
|
1154
WSFS Financial
WSFS
$4.17B
| $1.29M | ﹤0.01% |
28,607
-1,443
| -5% | -$62.8K |
|
1155
Riot Platforms
RIOT
$7.42B
| $1.29M | ﹤0.01% |
105,003
-5,297
| -5% | -$69K |
|
1156
Revolution Medicines
RVMD
$39B
| $1.28M | ﹤0.01% |
39,783
-2,007
| -5% | -$59.5K |
|
1157
Rogers Communications
RCI
$19.1B
| $1.28M | ﹤0.01% |
30,417
| – | – |
|
1158
Stride
LRN
$4.17B
| $1.28M | ﹤0.01% |
20,249
-1,021
| -5% | -$61.6K |
|
1159
Ziff Davis
ZD
$2.02B
| $1.28M | ﹤0.01% |
20,227
-1,020
| -5% | -$67.7K |
|
1160
InterDigital
IDCC
$6.83B
| $1.27M | ﹤0.01% |
11,964
-604
| -5% | -$63.8K |
|
1161
Brinker International
EAT
$8.94B
| $1.27M | ﹤0.01% |
25,628
-1,293
| -5% | -$57.2K |
|
1162
ACI Worldwide
ACIW
$6.18B
| $1.27M | ﹤0.01% |
38,294
-1,932
| -5% | -$59.7K |
|
1163
Home BancShares
HOMB
$6.34B
| $1.27M | ﹤0.01% |
51,660
-2,606
| -5% | -$62K |
|
1164
Cavco Industries
CVCO
$4.45B
| $1.27M | ﹤0.01% |
3,180
-160
| -5% | -$56.7K |
|
1165
Otter Tail
OTTR
$3.85B
| $1.27M | ﹤0.01% |
14,660
-740
| -5% | -$64.3K |
|
1166
LCI Industries
LCII
$2.6B
| $1.27M | ﹤0.01% |
10,280
-519
| -5% | -$61.1K |
|
1167
LiveRamp
RAMP
$2.3B
| $1.26M | ﹤0.01% |
36,653
-1,849
| -5% | -$68K |
|
|
SPR
1168
DELISTED
Spirit AeroSystems
SPR
| $1.26M | ﹤0.01% |
34,966
-1,764
| -5% | -$53.5K |
|
1169
Archrock
AROC
$6.23B
| $1.26M | ﹤0.01% |
64,087
-3,233
| -5% | -$55.2K |
|
1170
Biohaven
BHVN
$2.05B
| $1.26M | ﹤0.01% |
23,038
-139,501
| -86% | -$6.91M |
|
|
PLYA
1171
DELISTED
Playa Hotels & Resorts
PLYA
| $1.26M | ﹤0.01% |
129,640
-6,540
| -5% | -$57.8K |
|
1172
Roivant Sciences
ROIV
$23.9B
| $1.25M | ﹤0.01% |
118,378
-731,472
| -86% | -$7.89M |
|
|
JBTM
1173
JBT Marel
JBTM
$7.35B
| $1.25M | ﹤0.01% |
11,880
-599
| -5% | -$59.7K |
|
1174
MYR Group
MYRG
$5.11B
| $1.25M | ﹤0.01% |
7,045
-355
| -5% | -$54.6K |
|
1175
Haemonetics
HAE
$3.85B
| $1.24M | ﹤0.01% |
14,566
-735
| -5% | -$57.7K |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Ensign Peak Advisors held 1,776 positions worth $54.8B, up 8.4% from $50.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 5%. Ensign Peak Advisors opened 37 new positions and exited 51, leaving the 1,776-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q1 2024 buy was Blackstone Secured Lending: 3,319,725 shares worth $103M.
- Ensign Peak Advisors added most to Eli Lilly in Q1 2024, an estimated $158M increase.
- Ensign Peak Advisors's biggest Q1 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $184M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $66.5M.
- Ensign Peak Advisors's ten largest holdings make up 30% of its $54.8B portfolio in Q1 2024.
- Ensign Peak Advisors opened 37 new positions and closed 51 in Q1 2024.
- Ensign Peak Advisors's portfolio value rose 8.4% quarter-over-quarter to $54.8B.
Based on Ensign Peak Advisors's 13F filing for Q1 2024, filed 14 May 2024.